Shareholders Foundation, Inc.

Chemed Corporation (NYSE:CHE) Investor Alert: Investigation over Possible Violations of Securities Laws

An investigation for investors in Chemed Corporation (NYSE:CHE) shares over potential securities laws violations by Chemed Corporation was announced and NYSE:CHE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

 

San Diego, CA -- (SBWIRE) -- 05/06/2013 -- An investigation on behalf of investors of Chemed Corporation (NYSE:CHE) shares over potential securities laws violations by Chemed and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Chemed Corporation (NYSE:CHE), have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Chemed Corporation (NYSE:CHE) concerning whether a series of statements by Chemed regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Chemed Corporation (NYSE:CHE) reported that its annual Total Revenue rose from over $1.19 billion in 2009 to over $1.43 billion in 2012 and that its respective Net Income increased from $74.04 million to $89.30 million.

Shares of Chemed Corporation (NYSE:CHE) grew from $36.76 per share in July 2009 to $81.94 per share on May 2, 2013.

Then on May 2, 2013, the United States Department of Justice announced that a lawsuit was filed against Chemed Corporation and various wholly owned hospice subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, alleging false Medicare billings for hospice services. More specifically, the complaint by the United States Department of Justice alleges, among other things, that Chemed and Vitas knowingly submitted, or caused the submission of, false claims to Medicare for crisis care services that were not necessary, not actually provided, or not performed in accordance with Medicare requirements.

Shares of Chemed Corporation (NYSE:CHE) declined from almost $82 per share on May 2nd to $62.025 on May 3, 2013.

Those who purchased shares of Chemed Corporation (NYSE:CHE), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Trevor Allen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com